Cargando…
含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348278/ https://www.ncbi.nlm.nih.gov/pubmed/30369208 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.013 |
_version_ | 1783556773740806144 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7348278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73482782020-07-16 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2018-10 /pmc/articles/PMC7348278/ /pubmed/30369208 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.013 Text en 2018年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 短篇论著 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
title | 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
title_full | 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
title_fullStr | 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
title_full_unstemmed | 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
title_short | 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
title_sort | 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 |
topic | 短篇论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348278/ https://www.ncbi.nlm.nih.gov/pubmed/30369208 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.013 |
work_keys_str_mv | AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī |